International Clinical Trial: Ivonescimab combined with chemotherapy treated with recurrent/persistent ovarian, fallopian tube, or primary peritoneal clear cell carcinoma patients:a single arm, open-label , single center exploratory study

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115984) titled 'Ivonescimab combined with chemotherapy treated with recurrent/persistent ovarian, fallopian tube, or primary peritoneal clear cell carcinoma patients:a single arm, open-label , single center exploratory study' on Jan. 4.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: West China Second Hospital of Sichuan University

Condition: Ovarian clear cell carcinoma

Intervention: Experimental group:After enrollment, platinum-based chemotherapy was administered according to the type of platinum-sensitive or platinum-resistant recurrence. Platinum-sensitive relapse: everliximab 20mg/kg, admin...